Latest Acetylcholine Stories
NEW YORK, April 9 /PRNewswire/ -- According to Drs. Timothy Salthouse and Eric R. Braverman, the effects of the brain's cognitive abilities become less effective as early as our mid-twenties. A recent study by Dr.
Nicotine isn't just addictive, it may also interfere with dozens of cellular interactions in the body, U.S.
WATERTOWN, Mass., April 1, /PRNewswire/ -- EnVivo Pharmaceuticals today announced an agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) for the development and commercialization of its lead product candidate, EVP-6124, in Japan and several other Asian countries.
-A tiny genetic mutation is the key to understanding why nicotine--which binds to brain receptors with such addictive potency--is virtually powerless in muscle cells that are studded with the same type of receptor.
A research team led by Northwestern University reports that insulin may slow or prevent the damage and memory loss caused by toxic proteins affiliated with Alzheimerâ€™s disease.
Duke University Medical System researchers have discovered there are differing taste pathways for nicotine, which could provide a new approach for future smoking-cessation products.
MADISON, Wis., Jan. 12 /PRNewswire/ -- Mithridion, Inc., a drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease (AD), announced today that it held an initial closing of $2.9 million in Series B Preferred Stock financing.
Scientists have identified a relationship between two proteins in the brain that has links to both nicotine addiction and autism.
SARASOTA, Fla., Oct. 21 /PRNewswire/ -- A team of world-renowned scientists today announced the launch of Archer Pharmaceuticals, Inc., a new company that will use modern technologies for the identification of novel treatments for Alzheimer's disease.
REYKJAVIK, Iceland, Oct. 3 /PRNewswire-FirstCall/ -- deCODE genetics today announced the filing of an investigational new drug (IND) application for DG071, the company's novel small-molecule modulator of phosphodiesterase 4 (PDE4), with the US Food and Drug Administration (FDA).
- An imitative word; an onomatopoetic word.